IRIDEX CORP Accounts Receivable, Allowance for Credit Loss
IRIDEX CORP (IRIX) had Accounts Receivable, Allowance for Credit Loss of $112.00 thousand as of 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-08-18
- 2026-07-04: Accounts Receivable, Allowance for Credit Loss $112.00K.
- 2026-04-04: Accounts Receivable, Allowance for Credit Loss $112.00K.
- 2026-01-03: Accounts Receivable, Allowance for Credit Loss $112.00K.
- 2025-09-27: Accounts Receivable, Allowance for Credit Loss $112.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2026-07-04 | $112.00K 10-Q · filed 2026-08-18 |
| 2026-04-04 | $112.00K 10-Q · filed 2026-05-19 |
| 2026-01-03 | $112.00K 10-Q · filed 2026-08-18 |
| 2025-09-27 | $112.00K 10-Q · filed 2025-11-12 |
| 2025-06-28 | $112.00K 10-Q · filed 2025-08-12 |
| 2025-03-29 | $112.00K 10-Q · filed 2025-05-13 |
| 2024-12-28 | $259.00K 10-K · filed 2026-04-02 |
| 2024-09-28 | $112.00K 10-Q · filed 2024-11-12 |
| 2024-06-29 | $112.00K 10-Q · filed 2024-08-08 |
| 2024-03-30 | $112.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $9.70M 10-K · filed 2025-03-27 |
| 2023-12-30 | $146.00K 10-K · filed 2026-04-02 |
| 2023-09-30 | $146.00K 10-Q · filed 2023-11-20 |
| 2023-07-01 | $146.00K 10-Q · filed 2023-08-10 |
| 2023-04-01 | $146.00K 10-Q · filed 2023-05-11 |
| 2023-01-01 | $9.80M 10-K · filed 2025-03-27 |
| 2022-12-31 | $390.00K 10-K · filed 2025-03-27 |
| 2022-01-02 | $9.70M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |